Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05341206Phase 2Not yet recruiting
Phase 2, randomised trial in stomatitis and oral mucositis (OM), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Common Terminology Criteria for Adverse Events at 8 weeks. Planned start Apr 2022; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05341206.